% | $
Quotes you view appear here for quick access.

Incyte Corporation Message Board

  • viseslinger viseslinger Dec 28, 2012 5:36 AM Flag

    Why wait until 2013 for INCY

    Incyte Corporation (NASDAQ:INCY): JMP Securities expects Incyte Corporation to benefit from several important clinical data catalysts and an acceleration in revenue from their Jakafi drug for the treatment of Myelofibrosis. The firm recommends buying shares of Incyte in 2013.

93.20+4.13(+4.64%)Sep 28 4:00 PMEDT